Epsilon M&A Deal Report - LdPath (now Source LdPath)
Transaction Multiples for the Valuation of Private Companies
Sourcebio International / LdPath (now Source LdPath)
No EMAT :
116280
Announced Date :
08/03/2022
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Sourcebio International
Target :
LdPath (now Source LdPath)
Country :
United Kingdom
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Medical Diagnostic Laboratory
Business Description :
Co-founded in 2017 by Dr Alistair Robson, LDPath is a private histopathology provider in the United Kingdom . > Provides rapid histopathology reporting by specialist pathologists, delivering a...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
ns | ns |
|
||||
| Current |
|
|
|
|
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Diagnostic Laboratory » = 52
| Date | Acquirer | Target | Country | Multiples | See details |
| 26/09/2022 | GENinCode | Abcodia | United Kingdom | ** | 116272 |
| 03/04/2023 | Sonic Healthcare | Diagnosticum MVZ Diagnosticum | Germany | ** | 116268 |
Source: Epsilon Research / EMAT
